Search results
Results from the WOW.Com Content Network
Patiromer was generally well tolerated in studies. Side effects that occurred in more than 2% of patients included in clinical trials were mainly gastro-intestinal problems such as constipation, diarrhea, nausea, and flatulence, and also hypomagnesemia (low levels of magnesium in the blood) in 5% of patients, because patiromer binds magnesium in the gut as well.
Related: 5-Year-Old Girl Now Cancer-Free After Dentist Noticed Tumor in Her Jaw During Routine Visit Twelve of the patients died between 2 months and 7 years after the infusion, “all due to ...
Results from the first year study found smaller volumes of gray and white matter in patients exposed to chemotherapy. However, in the three-year study, both groups of breast cancer survivors were observed to have similar gray and white matter volumes. Altered brain structure in chemotherapy patients provides explanation for cognitive impairment ...
Medicine does not designate most long-term survivors as cured. The National Cancer Institute estimated 22,070 new cases of primary brain cancer and 12,920 deaths due to the illness in the United States in 2009. The age-adjusted incidence rate is 6.4 per 100,000 per year, and the death rate is 4.3 per 100,000 per year. The lifetime risk of ...
Cerebrolysin (developmental code name FPF-1070) is an experimental mixture of enzymatically-treated peptides derived from pig brain whose constituents can include brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF).
This mechanism leads to specific patterns of damage in DNA, which can kill cancer cells but can also increase the risk of secondary tumors developing. [ 6 ] Platinum-based antineoplastic agents are sometimes described as "alkylating-like" due to similar effects as alkylating antineoplastic agents , although they do not have an alkyl group.
Accurate, real time dosimetry to better estimate the radiation doses delivered to the tumor and normal tissues in patients with brain tumors and head and neck cancer. Further clinical evaluation of accelerator-based neutron sources for the treatment of brain tumors, head and neck cancer, and other malignancies. Reducing the cost.
For people with brain tumors, radiation can be an effective treatment because chemotherapy is often less effective due to the blood–brain barrier. [ citation needed ] Unfortunately for some patients, as time passes, people who received radiation therapy may begin experiencing deficits in their learning, memory, and spatial information ...